Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

At 17, I was like any other sixth-former. I was navigating A-levels, playing tuba in a youth brass band and planning my Duke ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

InhaleRX Ltd (ASX:IRX) – a company which develops inhaled drug-device treatments for pain management and a range of mental ...

Prostate cancer affects men all over the world and cutting edge research and clinical trials are happening right here in Madison. As part of our effort to raise ...

An international, multidisciplinary team of leading neuro-oncology researchers and clinicians has released new ...

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with ...

More clinical trials offering cutting-edge cancer care in Lancaster County will be among the changes if Dr. Efrat Dotan meets ...

New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

Ivermectin is an antiparasitic agent, and its potential as an anticancer agent has recently attracted increasing attention.